JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $55

JP Morgan maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $50 to $55.

Benzinga · 12/20/2019 14:22

JP Morgan maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $50 to $55.